Why German Doctors Have Been Prescribing This for Neuropathy Since 1966 — While American Doctors Still Reach for Gabapentin

By Margaret Collins, Health & Medicine Correspondent 6 minute read

If you have peripheral neuropathy — the burning, the stabbing, the numbness that peaks the moment you lie down at night — your American doctor has probably offered you one of four things.

 

Gabapentin. Pregabalin. Duloxetine. Or a suggestion to manage your blood sugar and hope for the best.

 

If you have been on any of those long enough, you already know they share one thing in common: none of them address what is actually happening to your nerve cells. They turn down the pain signal. The damage underneath keeps running.

 

What your doctor has almost certainly never mentioned is that neurologists in Germany have been treating peripheral neuropathy with a specific compound since 1966. Not as a supplement. As a prescribed pharmaceutical. With three major clinical trials behind it conducted across the United States, Canada and Europe. With a response rate that makes gabapentin look like a placebo.

 

The reason you have never heard of it has nothing to do with science. It has everything to do with money

 

What Is Actually Destroying Your Nerves

Before we get to the compound, you need to understand the specific biological process your current treatment is not addressing — because this is the reason everything you have tried has produced either partial results or none at all.

The standard explanation for diabetic and peripheral neuropathy is that elevated blood sugar damages nerve fibers over time. That is true but dangerously incomplete.

 

What the research shows — and what German neurologists identified decades ago — is that the primary driver of neuropathic progression is oxidative stress at the cellular level. Chronically elevated blood sugar triggers a cascade of free radical damage that literally strips your nerve cells of their internal antioxidant defense system. The nerve cells lose their supply of glutathione, Vitamin C, Vitamin E and CoQ10 — the compounds they need to survive and fire properly. The mitochondria that power nerve signal transmission begin to fail.

The nerves are not just damaged. They are being starved.

 

Here is the critical detail that explains why controlling your blood sugar — as important as that is — does not stop the progression: the oxidative cascade runs independently. It continues even after glycemic control improves. Which is why millions of people who have done everything right — perfect A1C, medication on schedule, lifestyle changes — still watch the numbness climb from their toes to their ankles to their knees year after year.

 

Gabapentin does not touch this process. Neither does Lyrica. Neither does duloxetine. They are all working on the signal. The damage runs underneath completely unaddressed.

 

LEARN MORE

What German Neurologists Found in 1966

Dr. Dan Ziegler, Diabetes Research Institute, Düsseldorf, Germany. Lead researcher on the ALADIN, SYDNEY and NATHAN trials.

Alpha-lipoic acid was first identified in 1937. In 1951, researcher Lester Reed's team at the University of Texas isolated it from bovine liver — an effort that required processing ten tons of liver residue to yield just 30 milligrams. 

 

German physicians began using it clinically in 1959 for acute mushroom poisoning and quickly noticed its utility for neuropathic complaints.

 

By 1966, Germany approved alpha-lipoic acid as a prescription drug for diabetic neuropathy.

 

That approval was not based on marketing. It was based on a specific biological property that no other antioxidant on earth shares: alpha-lipoic acid is the only compound that works in both water-soluble and fat-soluble environments simultaneously, crosses the blood-brain barrier, and regenerates every major antioxidant the body produces — Vitamin C, Vitamin E, glutathione and CoQ10 — essentially recharging the nerve cell's entire defense system from the inside.

 

Lester Packer of UC Berkeley called it the universal antioxidant. It was once considered a vitamin.

 

German neurologists recognized that this specific mechanism — recharging the nerve cell's antioxidant defense system — directly addressed the oxidative cascade destroying nerve cells in neuropathy patients. Not the symptom. The source.

 

LEARN MORE

The Clinical Trials Your Doctor Never Mentioned

Three landmark trials followed the German approval. All three were led or coordinated by Dr. Dan Ziegler at the Diabetes Research Institute in Düsseldorf, Germany — the neurologist who has spent 30 years studying this exact molecule on this exact condition.

 

ALADIN I — 1995 

328 Type 2 diabetic patients. Double-blind, placebo-controlled. Published in Diabetologia. The group taking 600mg of alpha-lipoic acid daily showed an 82.5% response rate — defined as 30% or greater improvement in neuropathic symptoms — compared to 57.6% for placebo. Total Symptom Score decreased by 63.5% in the treatment group.

82.5%. In a double-blind trial. Published in a peer-reviewed journal.

 

SYDNEY 2 — 2006 

181 diabetic patients on oral alpha-lipoic acid. Published in Diabetes Care. This trial was significant because it established that oral supplementation — not just intravenous administration — produces meaningful results. 600mg once daily was identified as the optimal dose for the best risk-to-benefit ratio.

 

NATHAN 1 — 2011 

460 patients across 36 centers in the United States, Canada and Europe. Four years of daily 600mg treatment. Published in Diabetes Care. Results showed clinically meaningful improvement and prevention of neuropathic progression over four years of use.

LEARN MORE

The Clinical Trials Your Doctor Never Mentioned

Three landmark trials followed the German approval. All three were led or coordinated by Dr. Dan Ziegler at the Diabetes Research Institute in Düsseldorf, Germany — the neurologist who has spent 30 years studying this exact molecule on this exact condition.

 

ALADIN I — 1995 

328 Type 2 diabetic patients. Double-blind, placebo-controlled. Published in Diabetologia. The group taking 600mg of alpha-lipoic acid daily showed an 82.5% response rate — defined as 30% or greater improvement in neuropathic symptoms — compared to 57.6% for placebo. Total Symptom Score decreased by 63.5% in the treatment group.

82.5%. In a double-blind trial. Published in a peer-reviewed journal.

 

SYDNEY 2 — 2006 

181 diabetic patients on oral alpha-lipoic acid. Published in Diabetes Care. This trial was significant because it established that oral supplementation — not just intravenous administration — produces meaningful results. 600mg once daily was identified as the optimal dose for the best risk-to-benefit ratio.

 

NATHAN 1 — 2011 

460 patients across 36 centers in the United States, Canada and Europe. Four years of daily 600mg treatment. Published in Diabetes Care. Results showed clinically meaningful improvement and prevention of neuropathic progression over four years of use.

Alpha-lipoic acid is roughly 2.5 times more likely to produce real relief than the drug 73 million Americans are currently taking for nerve pain.

 

Why Your Doctor Has Never Mentioned Any of This

Alpha-lipoic acid is a naturally occurring compound. It cannot be patented.

 

Without a patent there is no pharmaceutical company willing to fund the $100 million plus FDA drug approval process. Without FDA approval it cannot be classified as a drug in the United States. 

 

Without drug classification it cannot be included in American treatment guidelines. Without guidelines doctors do not learn about it in medical school. Without medical school education doctors do not prescribe it.

 

So it sits in the supplement aisle at doses that may or may not be effective, in forms that may or may not be the right molecule, while the doctors who trained on gabapentin keep writing prescriptions for gabapentin.

 

Gabapentin is now the 5th most prescribed drug in America. 73 million prescriptions in 2023. Not because it works better than R-ALA. Because it can be patented and R-ALA cannot.

 

LEARN MORE

The Wrong Form Problem — Why Your Previous ALA Did Nothing

Here is the detail that explains why millions of people who have tried alpha-lipoic acid felt nothing.

 

The alpha-lipoic acid sold in most American supplement stores — at GNC, at Walmart, on Amazon — is racemic ALA. A 50/50 mixture of the natural R-form and a synthetic mirror molecule called S-ALA.

 

Your body only recognizes the R-form. The R-form is what appears naturally in food. The R-form is what nerve cell receptors are designed to work with. The R-form is what was used in every clinical trial referenced above.

 

The S-form does not just fail to help. Research suggests it may actively compete with the R-form for the same receptor sites — effectively blocking the active molecule from doing its job.

 

You were not taking the wrong supplement. You were taking the wrong half of it.

 

The product you need is specifically stabilized R-Alpha Lipoic Acid — the pure R-form, stabilized to prevent degradation before absorption, delivered at 600mg daily, the exact dose used in the ALADIN, SYDNEY and NATHAN trials. 

 

Delivered in a fat-soluble form with coconut oil because R-ALA absorption increases significantly in fat-soluble environments.

 

Most products on the market fail on at least one of those variables. Wrong form. Wrong dose. Unstabilized. Poor delivery. Any one of those failures produces the result you may have already experienced: nothing.

LEARN MORE

Root of Natures 
Stabilized pure R-Alpha Lipoic Acid. 600mg per serving. 
The exact form and dose used in the ALADIN, SYDNEY and NATHAN trials. 
No proprietary blends. No hidden doses. Everything on the label exactly as the research requires.

Stabilized R-ALA 600mg - Stop the Burning, Tingling & Numbness from Neuropathy

BUY NOW

Sell-out Risk: High

|

BUY MORE SAVE MORE

Try it today with a 60-Day Money Back Guarantee!

Hear from Our Customers

30,000 Happy Customer

LEARN MORE
Title

Copyright © 2024. All Rights Reserved.

Refund policy

Terms of service

Privacy policy

Try it today with a 60-Day Money Back Guarantee!

LEARN MORE